Rare diseases
Investigational molecules
Locations
Back to Germany12 clinical trials in Coswig, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on Progressive Pulmonary Fibrosis (PPF) and Idiopathic Pulmonary Fibrosis (IPF), evaluating innovative inhaled treatments to improve lung function and patient outcomes.
Multiple Phase 3 studies are examining both short and long-term treatment effects in patients with fibrotic conditions.
Research initiatives targeting Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs), with trials designed to assess new therapeutic approaches for reducing lung function decline.
Comprehensive studies examining both established and experimental treatments for various forms of lung fibrosis.
Investigation of new compounds including bexotegrast and other innovative medications for treating various forms of pulmonary fibrosis and related conditions.
Multiple parallel studies are evaluating different therapeutic approaches to address various manifestations of fibrotic lung disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
